Mathews AA, Draganov PV, Yang D. Endoscopic management of colorectal polyps: From benign to malignant polyps. World J Gastrointest Endosc 2021; 13(9): 356-370 [PMID: 34630886 DOI: 10.4253/wjge.v13.i9.356]
Corresponding Author of This Article
Dennis Yang, FACG, FASGE, MD, Associate Professor, Division of Gastroenterology, Hepatology and Nutrition, University of Florida, 1329 SW 16TH Street, Room #5254, Gainesville, FL 32608, United States. dennis.yang@medicine.ufl.edu
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Endosc. Sep 16, 2021; 13(9): 356-370 Published online Sep 16, 2021. doi: 10.4253/wjge.v13.i9.356
Endoscopic management of colorectal polyps: From benign to malignant polyps
April A Mathews, Peter V Draganov, Dennis Yang
April A Mathews, Division of Pediatric Gastroenterology, University of Florida, Gainesville, FL 32608, United States
Peter V Draganov, Dennis Yang, Division of Gastroenterology, Hepatology and Nutrition, University of Florida, Gainesville, FL 32608, United States
Author contributions: Mathews AA and Yang D were involved in the literature search and drafting of the initial manuscript; all authors were involved in the final revision and approval of the manuscript.
Conflict-of-interest statement: Dennis Yang: Consultant for Boston Scientific, Lumendi; Steris Peter V Draganov: Consultant for Boston Scientific, Cook Medical, Olympus America, Lumendi, Microtech, Merit, Fujifilm.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Dennis Yang, FACG, FASGE, MD, Associate Professor, Division of Gastroenterology, Hepatology and Nutrition, University of Florida, 1329 SW 16TH Street, Room #5254, Gainesville, FL 32608, United States. dennis.yang@medicine.ufl.edu
Received: March 11, 2021 Peer-review started: March 11, 2021 First decision: April 6, 2021 Revised: May 17, 2021 Accepted: August 9, 2021 Article in press: August 9, 2021 Published online: September 16, 2021
Core Tip
Core Tip: Endoscopic resection is a proven strategy for the management of benign and selected malignant colorectal polyps. When compared to surgery, endoscopic resection is less costly and associated with improved clinical outcomes and patient satisfaction. Detailed lesion assessment, including endoscopic imaging and histopathology, play a critical role in directing subsequent treatment strategies. Ultimately, the most appropriate intervention will depend on various factors, including patient and lesion characteristics, as well as local resources and expertise availability. Establishing the multidisciplinary collaboration between referring physicians, endoscopists, surgeons and pathologists is the basis for ensuring best practices for the management of colorectal polyps.
